Adolescent Who Holds Her Hand to Her Face

Positive findings from a repeat dosing study of neffy under nasal allergen challenge conditions will support a potential PDUFA date of October 2, 2024, the company said.

Now FDA approved, Optinose’s Xhance is the first nonsurgical option for chronic rhinosinusitis both with and without nasal polyps.

The Asthma and Allergy Foundation of America recently released its annual Allergy Capitals™ report. Which cities are most challenging for patients with seasonal allergies?

Patient claims pruritic full-body rash is from a course of vancomycin. Is he correct? Could it be something else?

Patient is 54 y/o man; the cough has been present for 2 weeks, the rash on the lower extremities for 2 months; the rash is getting worse. What's your dx?

Guttate and other psoriasis may be confused with other rashes and skin lesions. Scratch the surface of your knowledge with this crash quiz.